← Open Payments lookup

STACEY WATNE: Open Payments

NPI 1518621465 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,346 in 86 payments from 26 companies in 2025. Trend: 2023 $1,329 · 2024 $954 · 2025 $1,346

Food & beverage: $1,346
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.9$196
PFIZER INC.13$195
Lilly USA, LLC16$170
Otsuka America Pharmaceutical, Inc.11$169
Boehringer Ingelheim Pharmaceuticals, Inc.6$112
Teva Pharmaceuticals USA, Inc.3$48
AstraZeneca Pharmaceuticals LP3$45
Novo Nordisk Inc3$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Novartis Pharmaceuticals Corporation2$32

Products named: GEMTESA, REXULTI, MOUNJARO, JARDIANCE, AUSTEDO XR, ELIQUIS, NURTEC ODT, VYNDAMAX.

Industry payments across NE — which companies pay providers there.